腎臟活體捐贈者的風險評估
Risk Assessment of Living Kidney Donors

作者:邱炳芳(Ping-Fang Chiu)；蔡俊傑(Jyun-Jie Trai)

摘要
台灣透析人口仍逐漸增加，但台灣透析病人5年存活率約6成。為增加病人的存活及生活品質，腎臟移植為一重要方法。然而移植器官的短缺限制腎臟移植的發展，因此活體腎臟移植成為一個重要方式。2017年改善全球腎臟病預後組織（Kidney Disease: Improving Global Outcomes， KDIGO）發表了活體捐贈者評估照護指引，為移植評估提供一個重要參考指標。其中建議腎絲球過濾率＜ 60 ml/min/1.73 m^2，白蛋白排出率＞ 100 mg/day，以及申明第一型糖尿病為移植禁忌症，並且建議依長期末期腎病變風險決定是否可接受為捐贈者。
In Taiwan， patients with end-stage renal disease (ESRD) was increasing， but the five-year survival rate of ESRD patients was about 60%. For improving survival rate and quality of life of our ESRD patients， renal transplantation is an important treatment choice. However， the renal graft shortage limits development of renal transplantation in Taiwan. In 2017， Kidney Disease: Improving Global Outcomes (KDIGO) publish the guideline on evaluation and care of living donor candidate. This guideline is an important consult and advises that glomerular filtration rate ＜ 60 ml/ min/1.73 m^2， albumin excretion rate ＞ 100 mg/day or type 1 diabetes mellitus (DM) are contraindication for living donor nephrectomy. The guideline also proposes that we should accept the donor candidate under an acceptable long term ESRD risk which estimated by complete evaluation.

出處:腎臟與透析；30卷1期(2018/03/01)，P1-5